These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Author: Rus H, Cudrici C, Niculescu F, Shin ML.
    Journal: J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199.
    Abstract:
    Multiple sclerosis and its animal model experimental allergic encephalomyelitis are inflammatory demyelinating diseases of the central nervous system mediated by activated lymphocytes, macrophages/microglia and the complement system. Complement activation and the C5b-9 terminal complex contribute to the pathogenesis of these diseases through its role to promote demyelination. C5b-9 was also shown to protect oligodendrocytes from apoptosis both in vitro and in vivo. Our findings indicate that activation of complement and C5b-9 assembly plays a pro-inflammatory role in the acute phase, but may also be neuroprotective.
    [Abstract] [Full Text] [Related] [New Search]